Latest Insider Transactions at Surmodics Inc (SRDX)
This section provides a real-time view of insider transactions for Surmodics Inc (SRDX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of SURMODICS INC to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of SURMODICS INC's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 30
2022
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,342
-1.06%
|
$48,312
$36.13 P/Share
|
|
Nov 30
2022
|
Gary R Maharaj President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
24,356
+12.4%
|
-
|
|
Nov 30
2022
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
5,407
-1.78%
|
$194,652
$36.13 P/Share
|
|
Nov 30
2022
|
John D. Manders Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
2,075
+23.41%
|
-
|
|
Nov 30
2022
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
244
-2.49%
|
$8,784
$36.13 P/Share
|
|
Nov 30
2022
|
Charles W Olson SVP, Medical Device Coatings |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+10.72%
|
-
|
|
Nov 30
2022
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
1,342
-1.61%
|
$48,312
$36.13 P/Share
|
|
Nov 30
2022
|
Teri Woodwick Sides SVP, Vascular Interventions |
BUY
Grant, award, or other acquisition
|
Direct |
8,303
+22.86%
|
-
|
|
Nov 30
2022
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
902
-2.21%
|
$32,472
$36.13 P/Share
|
|
Nov 30
2022
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+9.24%
|
-
|
|
Nov 30
2022
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
1,449
-1.45%
|
$52,164
$36.13 P/Share
|
|
Nov 30
2022
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
BUY
Grant, award, or other acquisition
|
Direct |
5,535
+25.61%
|
-
|
|
Nov 30
2022
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
902
-4.13%
|
$32,472
$36.13 P/Share
|
|
Nov 28
2022
|
Jose H Bedoya |
SELL
Open market or private sale
|
Direct |
4,366
-15.29%
|
$148,444
$34.89 P/Share
|
|
Nov 28
2022
|
Jose H Bedoya |
BUY
Exercise of conversion of derivative security
|
Direct |
4,366
+13.26%
|
$87,320
$20.18 P/Share
|
|
Nov 25
2022
|
Charles W Olson SVP, Medical Device Coatings |
SELL
Payment of exercise price or tax liability
|
Direct |
471
-1.11%
|
$16,956
$36.02 P/Share
|
|
Nov 25
2022
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
543
-0.84%
|
$19,548
$36.02 P/Share
|
|
Nov 25
2022
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
586
-1.15%
|
$21,096
$36.02 P/Share
|
|
Nov 25
2022
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,172
-1.4%
|
$78,192
$36.02 P/Share
|
|
Nov 25
2022
|
John D. Manders Corporate Controller |
SELL
Payment of exercise price or tax liability
|
Direct |
61
-1.22%
|
$2,196
$36.02 P/Share
|
|
Nov 25
2022
|
Teri Woodwick Sides SVP, Vascular Interventions |
SELL
Payment of exercise price or tax liability
|
Direct |
365
-1.74%
|
$13,140
$36.02 P/Share
|
|
Nov 14
2022
|
David Dantzker |
SELL
Open market or private sale
|
Direct |
2,773
-7.5%
|
$91,509
$33.0 P/Share
|
|
Nov 14
2022
|
David Dantzker |
BUY
Exercise of conversion of derivative security
|
Direct |
4,366
+10.57%
|
$87,320
$20.18 P/Share
|
|
Nov 11
2022
|
Ronald B Sr Kalich |
SELL
Open market or private sale
|
Direct |
2,733
-8.3%
|
$90,189
$33.48 P/Share
|
|
Nov 11
2022
|
Ronald B Sr Kalich |
BUY
Exercise of conversion of derivative security
|
Direct |
4,366
+11.71%
|
$87,320
$20.18 P/Share
|
|
Sep 30
2022
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
587
+2.01%
|
$17,610
$30.4 P/Share
|
|
Jul 19
2022
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Payment of exercise price or tax liability
|
Direct |
15,386
-23.32%
|
$553,896
$36.73 P/Share
|
|
Jul 19
2022
|
Joseph J. Stich SVP of HR, President IVD |
BUY
Exercise of conversion of derivative security
|
Direct |
19,927
+23.25%
|
$398,540
$20.25 P/Share
|
|
Jun 30
2022
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
480
+1.69%
|
$17,760
$37.23 P/Share
|
|
May 13
2022
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
151
-0.23%
|
$5,285
$35.91 P/Share
|
|
May 12
2022
|
Gordon S. Weber Sr. VP of Legal, GC and Sec. |
SELL
Payment of exercise price or tax liability
|
Direct |
339
-2.95%
|
$11,526
$34.33 P/Share
|
|
Apr 01
2022
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
100
-0.06%
|
$4,500
$45.55 P/Share
|
|
Apr 01
2022
|
Gary R Maharaj President & CEO |
SELL
Open market or private sale
|
Direct |
3,900
-2.45%
|
$171,600
$44.97 P/Share
|
|
Mar 31
2022
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
394
+1.41%
|
$17,730
$45.33 P/Share
|
|
Feb 28
2022
|
Susan E Knight |
SELL
Open market or private sale
|
Direct |
4,366
-12.63%
|
$192,104
$44.97 P/Share
|
|
Feb 28
2022
|
Susan E Knight |
BUY
Exercise of conversion of derivative security
|
Direct |
4,366
+11.22%
|
$87,320
$20.18 P/Share
|
|
Feb 12
2022
|
Nusrath Sultana VP, Clinical Affairs |
SELL
Payment of exercise price or tax liability
|
Direct |
762
-10.45%
|
$31,242
$41.67 P/Share
|
|
Feb 10
2022
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+4.05%
|
-
|
|
Feb 10
2022
|
Lisa Wipperman Heine |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+12.45%
|
-
|
|
Feb 10
2022
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+4.83%
|
-
|
|
Feb 10
2022
|
Susan E Knight |
BUY
Grant, award, or other acquisition
|
Direct |
1,482
+4.68%
|
-
|
|
Feb 10
2022
|
Jose H Bedoya |
BUY
Grant, award, or other acquisition
|
Direct |
1,375
+5.38%
|
-
|
|
Jan 04
2022
|
Joseph J. Stich SVP of HR, President IVD |
SELL
Open market or private sale
|
Direct |
2,500
-5.17%
|
$125,000
$50.0 P/Share
|
|
Dec 31
2021
|
Ronald B Sr Kalich |
BUY
Grant, award, or other acquisition
|
Direct |
371
+1.42%
|
$17,808
$48.15 P/Share
|
|
Dec 31
2021
|
David Dantzker |
BUY
Grant, award, or other acquisition
|
Direct |
389
+1.23%
|
$18,672
$48.15 P/Share
|
|
Nov 30
2021
|
Timothy J. Arens Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
4,552
+6.58%
|
-
|
|
Nov 30
2021
|
Timothy J. Arens Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
650
-1.07%
|
$27,950
$43.93 P/Share
|
|
Nov 30
2021
|
Gary R Maharaj President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
18,210
+10.29%
|
-
|
|
Nov 30
2021
|
Gary R Maharaj President & CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
2,639
-1.84%
|
$113,477
$43.93 P/Share
|
|
Nov 30
2021
|
John D. Manders Corporate Controller |
BUY
Grant, award, or other acquisition
|
Direct |
1,707
+26.48%
|
-
|